CTLA4 and neoplasm: Besides, the combined inhibition of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and VISTA is more efficacious, and could increase CD8/Treg and Tcon/Treg ratios in the tumor microenvironment (TME) (14).